Diabetes & Vascular Disease Research

Impact of antidiabetic agents on COPD exacerbations in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis

By Muhammed Shabil, Asif Jan, Muhammad Aaqib Shamim, Shubham Kumar

Meta-analysis of observational studiesInterventions

755,206 participants

The paper

Muhammed Shabil, Asif Jan, Muhammad Aaqib Shamim, Shubham Kumar

M S Ramaiah University of Applied Sciences; Dr. D.Y. Patil Vidyapeeth, Pune

Diabetes & Vascular Disease Research, 1 Sep 2026

doi.org/10.1177/14791641261487590 PubMed 42821775

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes